Works by Yilmaz, Bulent


Results: 223
    1
    2
    3
    4
    5
    6

    Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience.

    Published in:
    Oncologist, 2023, v. 28, n. 8, p. 714, doi. 10.1093/oncolo/oyad039
    By:
    • Nardo, Mirella;
    • Yilmaz, Bulent;
    • Nelson, Blessie Elizabeth;
    • Torres, Harrys A;
    • Wang, Lan Sun;
    • Granwehr, Bruno Palma;
    • Song, Juhee;
    • Pria, Hanna R F Dalla;
    • Trinh, Van A;
    • Oliva, Isabella C Glitza;
    • Patel, Sapna P;
    • Tannir, Nizar M;
    • Kaseb, Ahmed Omar;
    • Altan, Mehmet;
    • Lee, Sunyoung S;
    • Miller, Ethan;
    • Zhang, Hao;
    • Stephen, Bettzy A;
    • Naing, Aung
    Publication type:
    Article
    7

    Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors.

    Published in:
    Oncologist, 2021, v. 26, n. 7, p. 558, doi. 10.1002/onco.13682
    By:
    • Tsimberidou, Apostolia‐Maria;
    • Vo, Henry Hiep;
    • Subbiah, Vivek;
    • Janku, Filip;
    • Piha‐Paul, Sarina;
    • Yilmaz, Bulent;
    • Gong, Jing;
    • Naqvi, Mohammad Faraz;
    • Tu, Shi‐Ming;
    • Campbell, Matthew;
    • Meric‐Bernstam, Funda;
    • Naing, Aung
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Hitit Devlet Arşiv-Kütüphanesi.

    Published in:
    Library, Archive & Museum Research Journal (LAMRe) / Kütüphane Arşiv ve Müze Araştırmaları Dergisi, 2024, v. 5, n. 2, p. 151, doi. 10.59116/lamre.1464134
    By:
    • YILAL, Satı Nur;
    • YILMAZ, Bülent
    Publication type:
    Article
    32
    33
    34
    35
    37
    38
    39

    Kripto Para: Bitcoin ve Döviz Kurları Üzerine Etkileri.

    Published in:
    Bartin University Journal of Faculty of Economics & Administrative Sciences / Bartın Üniversitesi İktisadi ve İdari Bilimler Fakültesi Dergisi, 2015, v. 6, n. 11, p. 247
    By:
    • ATİK, Murat;
    • KÖSE, Yaşar;
    • YILMAZ, Bülent;
    • SAĞLAM, Fatih
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47

    Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple‐negative breast cancer.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 14, p. 2201, doi. 10.1002/cncr.34773
    By:
    • Nelson, Blessie Elizabeth;
    • Saleem, Sadia;
    • Damodaran, Senthil;
    • Somaiah, Neeta;
    • Piha‐Paul, Sarina;
    • Moore, Julia Ann;
    • Yilmaz, Bulent;
    • Ogbonna, Deby;
    • Karp, Daniel D.;
    • Dumbrava, Ecaterina;
    • Tsimberidou, Apostolia M.;
    • Hong, David S.;
    • Rodon Ahnert, Jordi;
    • Milton, Denái R.;
    • Zheng, Xiaofeng;
    • Booser, Daniel J.;
    • Ibrahim, Nuhad K.;
    • Conley, Anthony P.;
    • Bhosale, Priya;
    • Rojas Hernandez, Cristhiam M.
    Publication type:
    Article
    48
    49
    50